Published in Nucleic Acids Res on July 15, 2002
Enhanced targeting with heterobivalent ligands. Mol Cancer Ther (2009) 1.21
Broccoli: rapid selection of an RNA mimic of green fluorescent protein by fluorescence-based selection and directed evolution. J Am Chem Soc (2014) 1.20
Regulation of FGF1 gene promoter through transcription factor RFX1. J Biol Chem (2010) 0.92
Promoter specificity and interactions between early and late Arabidopsis heat shock factors. Plant Mol Biol (2010) 0.86
Establishment of gene transfer and gene silencing methods in a desiccation-tolerant cell line, Pv11. Extremophiles (2016) 0.82
Construction of novel chloroplast expression vector and development of an efficient transformation system for the diatom Phaeodactylum tricornutum. Mar Biotechnol (NY) (2014) 0.82
Improvement of the fluorescence intensity during a flow cytometric analysis for rice protoplasts by localization of a green fluorescent protein into chloroplasts. Int J Mol Sci (2014) 0.78
Comparative analysis of macrophage associated vectors for use in genetic vaccine. Genet Vaccines Ther (2011) 0.77
Identification, cloning, and functional analysis of the TATA-less mouse FNDC5 promoter during neural differentiation. Cell Mol Neurobiol (2014) 0.75
Expression and Secretion of Cyan Fluorescent Protein (CFP) in B. subtilis using the Chitinase Promoter from Bacillus pumilus SG2 Iran Biomed J (2017) 0.75
Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci U S A (1994) 10.50
Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem (1998) 5.22
Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res (1996) 4.79
Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene (1991) 4.21
Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res (1996) 3.55
Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nat Biotechnol (1996) 1.70
Simultaneous fluorescence-activated cell sorter analysis of two distinct transcriptional elements within a single cell using engineered green fluorescent proteins. Proc Natl Acad Sci U S A (1996) 1.61
Production and characterization of monoclonal anti-Thy-1 antibodies that stimulate lymphokine production by cytolytic T cell clones. Eur J Immunol (1985) 1.25
Polarity of endogenous and exogenous glycosyl-phosphatidylinositol-anchored membrane proteins in Madin-Darby canine kidney cells. J Cell Sci (1990) 1.03
Characterization of NFkappaB activation by detection of green fluorescent protein-tagged IkappaB degradation in living cells. J Biol Chem (1999) 1.00
Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science (2007) 6.33
Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell (2004) 4.79
Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity (2011) 2.82
Telomere length homeostasis requires that telomerase levels are limiting. EMBO J (2006) 2.81
TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol Cell Biol (2010) 2.39
The Rat1p 5' to 3' exonuclease degrades telomeric repeat-containing RNA and promotes telomere elongation in Saccharomyces cerevisiae. Mol Cell (2008) 2.36
The human RNA surveillance factor UPF1 is required for S phase progression and genome stability. Curr Biol (2006) 2.16
A human homolog of yeast Est1 associates with telomerase and uncaps chromosome ends when overexpressed. Curr Biol (2003) 2.14
Telomere length homeostasis. Chromosoma (2006) 2.12
Telomerase: biochemical considerations for enzyme and substrate. Trends Biochem Sci (2002) 2.07
The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res (2010) 2.05
Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation. Mol Cell (2007) 2.03
Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol Cell Biol (2005) 1.94
TERRA: telomeric repeat-containing RNA. EMBO J (2009) 1.94
Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways. Mol Cell Biol (2010) 1.89
The human CST complex is a terminator of telomerase activity. Nature (2012) 1.81
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood (2003) 1.78
Telomerase repeat addition processivity is increased at critically short telomeres in a Tel1-dependent manner in Saccharomyces cerevisiae. Genes Dev (2007) 1.67
Regulation of the human telomerase reverse transcriptase gene. Oncogene (2002) 1.47
Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J Biol Chem (2002) 1.40
Incorporation of reporter molecule-labeled nucleotides by DNA polymerases. II. High-density labeling of natural DNA. Nucleic Acids Res (2003) 1.39
Intracellular trafficking of yeast telomerase components. EMBO Rep (2002) 1.34
Telomeres: the silence is broken. Cell Cycle (2008) 1.32
TERRA biogenesis, turnover and implications for function. FEBS Lett (2010) 1.31
Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action. Proc Natl Acad Sci U S A (2007) 1.29
Tel1 kinase and subtelomere-bound Tbf1 mediate preferential elongation of short telomeres by telomerase in yeast. EMBO Rep (2007) 1.26
Structure of active dimeric human telomerase. Nat Struct Mol Biol (2013) 1.23
Telomerase limits the extent of base pairing between template RNA and telomeric DNA. EMBO Rep (2005) 1.20
Saccharomyces cerevisiae Ebs1p is a putative ortholog of human Smg7 and promotes nonsense-mediated mRNA decay. Nucleic Acids Res (2007) 1.18
The PIAS homologue Siz2 regulates perinuclear telomere position and telomerase activity in budding yeast. Nat Cell Biol (2011) 1.17
TERRA promotes telomere shortening through exonuclease 1-mediated resection of chromosome ends. PLoS Genet (2012) 1.13
Protein RNA and protein protein interactions mediate association of human EST1A/SMG6 with telomerase. Nucleic Acids Res (2007) 1.13
Subtelomeric repetitive elements determine TERRA regulation by Rap1/Rif and Rap1/Sir complexes in yeast. EMBO Rep (2011) 1.13
The double life of UPF1 in RNA and DNA stability pathways. Cell Cycle (2006) 1.08
The THO complex component Thp2 counteracts telomeric R-loops and telomere shortening. EMBO J (2013) 1.07
A quantitative telomeric chromatin isolation protocol identifies different telomeric states. Nat Commun (2013) 1.04
Replication of telomeres and the regulation of telomerase. Cold Spring Harb Perspect Biol (2013) 1.03
Low- to high-throughput analysis of telomerase modulators with Telospot. Nat Methods (2007) 1.02
A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models. Vaccine (2012) 0.97
The finger subdomain of yeast telomerase cooperates with Pif1p to limit telomere elongation. Nat Struct Mol Biol (2006) 0.97
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes. PLoS One (2013) 0.96
CST for the grand finale of telomere replication. Nucleus (2013) 0.94
Yeast telomerase is specialized for C/A-rich RNA templates. Nucleic Acids Res (2003) 0.93
Molecular basis of telomere syndrome caused by CTC1 mutations. Genes Dev (2013) 0.92
A three-state model for the regulation of telomerase by TERRA and hnRNPA1. Nucleic Acids Res (2013) 0.92
Incorporation of reporter molecule-labeled nucleotides by DNA polymerases. I. Chemical synthesis of various reporter group-labeled 2'-deoxyribonucleoside-5'-triphosphates. Nucleic Acids Res (2003) 0.91
Telomerase is essential to alleviate pif1-induced replication stress at telomeres. Genetics (2009) 0.90
Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate. ACS Chem Biol (2006) 0.88
A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses. Vaccine (2007) 0.85
Influenza virosomes as a vaccine adjuvant and carrier system. Expert Rev Vaccines (2011) 0.85
Gene expression analysis using single molecule detection. Nucleic Acids Res (2003) 0.85
Influenza virosomes as vaccine adjuvant and carrier system. Expert Rev Vaccines (2013) 0.85
Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations. Expert Rev Vaccines (2007) 0.85
Telomere length homeostasis responds to changes in intracellular dNTP pools. Genetics (2013) 0.84
Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells. Vaccine (2007) 0.83
Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations. Malar J (2011) 0.82
Cell biology. Telomere wedding ends in divorce. Science (2004) 0.82
Telomerase unplugged. ACS Chem Biol (2007) 0.82
A chromosome 3-encoded repressor of the human telomerase reverse transcriptase (hTERT) gene controls the state of hTERT chromatin. Cancer Res (2003) 0.81
Cell signaling. Tel2 finally tells one story. Science (2008) 0.80
Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro. Vaccine (2005) 0.79
Molecular biology: damage control. Nature (2007) 0.79
Specific binding of telomeric G-quadruplexes by hydrosoluble perylene derivatives inhibits repeat addition processivity of human telomerase. Biochimie (2011) 0.78
Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells. Vaccine (2009) 0.78
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. Cancer Lett (2008) 0.78
Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships. Immunology (2015) 0.78
An affinity oligonucleotide displacement strategy to purify ribonucleoprotein complexes applied to human telomerase. Methods Mol Biol (2008) 0.77
Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease. J Mol Neurosci (2005) 0.77
Virosomes can enter cells by non-phagocytic mechanisms. J Liposome Res (2009) 0.77
Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites. Eur Cytokine Netw (2002) 0.76
Telomerase inhibitors from cyanobacteria: isolation and synthesis of sulfoquinovosyl diacylglycerols from Microcystis aeruguinosa PCC 7806. Chemistry (2013) 0.76
Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technology. Hum Vaccin (2007) 0.76
Related mechanisms for end processing at telomeres and DNA double-strand breaks. Mol Cell (2009) 0.76
AUF1/HnRNP D RNA binding protein functions in telomere maintenance. Mol Cell (2012) 0.76
Fingering the ends: how to make new telomeres. Cell (2003) 0.75
[Telomerase, elixir of life for human cells?]. Med Sci (Paris) (2003) 0.75
Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy. J Liposome Res (2006) 0.75